Grants

Explore our active grants awarded to fund advancements in health care through the use of AI.

  • $6.8 million VA award over four years on use of multimodal AI for prostate cancer risk stratification in Veteran patients.
  • $6.7 million VA award over four years on predicting metastatic progression of high risk localized prostate cancer. (08/14/23-08/13/27)
  • $4.9 million Case Western Reserve University award over five years on lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging. (09/21/20-08/31/25)
  • $4.7 million NIH award over five years on Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern. (07/12/23–06/30/28)
  • $4.6 million VA award over four years for pioneering research in utilizing multimodal AI to enhance head and neck cancer risk stratification in Veteran patients.
  • $4.5 million VA award over four years on an imaging AI-driven predictive chemoradiation response tool for Veterans with oropharyngeal cancer. (04/01/24-03/30/28)
  • $3.3 million NIH award over six years on Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC).
  • $3.3 million Cleveland Clinic Foundation award over five years on imaging signatures of early tuberculosis. (12/30/20 – 08/31/26)
  • $3.2 million University of Wisconsin-Madison award over five years on quantitative imaging phenotypic classifier for distinguishing radiation effects from tumor recurrence in Glioblastoma. (07/01/22-06/30/27)
  • $3.1 million NIH award over five years on prognostic and predictive digital tissue image assay for prostate cancer. (09/05/22-08/31/27)
  • $3.1 million NIH award over five years on prostate cancer risk stratification via computational 3D pathology. (07/01/22-06/30/27)
  • $3.1 million NIH award over six years on Computerized Histologic Risk Predictor (CHiRP) for early stage lung cancers. (01/01/18-12/31/24)
  • $3.1 million NIH award over seven years on Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV and oropharyngeal carcinoma. (3/08/18-3/07/25)
  • $3.1 million NIH award over five years on computer-assisted histologic evaluation of cardiac allograft rejection. (12/30/20-12/29/25)
  • $2.9 million NIH award over four years on novel radiomic approaches to improve targeting for atrial fibrillation catheter ablation. (07/07/21–07/06/25)
  • $2.8 million NIH award over five years on an AI-enabled digital pathology platform for multi-cancer diagnosis, prognosis and prediction of therapeutic benefit. (09/05/22 -08/31/27)
  • $2.3 million VA award over five years on VA Hub for Computer Vision and Machine Learning in Precision Oncology (CoMPL) (12/01/21-11/30/26)
  • $1.3 million NIH award over four years on histotools: scaling digital pathology curation tools for quality control, annotation, labeling, and dataset identification. (09/21/22–08/30/26)
  • $1.1 million VA award over three years on a novel radiomics toolkit to predict and characterize response to immunotherapy in Stage III non-small cell lung cancer. (01/01/23-12/31/26)
  • $1 million DoD award over three years on race-specific 3D computational pathology biomarkers for predicting prostate cancer-specific recurrence. (09/01/20-08/31/23)
  • $694,449 National Science Foundation award over four years on MRI: Acquisition of Artificial Intelligence Super Computer (AISC) for accelerating scientific discovery. (10/10/21–03/09/25)
  • $636,307 Astrazeneca award over three years on Novel Radiomics on CT for predicting treatment response for immunotherapy for lung cancer. (02/16/24–02/15/27)
  • $626,001 DoD award over three years on quantitative image analysis tool for prognosticating disease-free survival of patients with oral cavity squamous cell carcinoma. (06/01/22-05/30/25)
  • $600,000 Bristol-Meyers Squibb award over two years on integrated radiomics and pathomics to predict response to immune checkpoint inhibitors. (11/23/22-11/22/24)
  • $594,294 DoD award over three years on DigiTIL, a computational histomorphometric predictor of disease recurrence and overall survival for p16-positive oropharyngeal squamous cell carcinoma. (12/01/22–04/14/25)
  • $577,781 DoD award over two years on novel radiogenomic tools for outcome prediction for small cell lung cancer patients treated with chemoimmunotherapy. (01/01/24-12/31/26)
  • $466,462 Cleveland Clinic Foundation award over four years on determination of radiogenomic markers for prediction of atrial fibrillation risk and ablation outcomes. (07/01/20-06/30/24)
  • $412,728 Cleveland Clinic Foundation award over two years on integrated, computer aided point of care ultrasound for tuberculosis screening. (07/01/22-06/30/24)
  • $200,000 Bayer PHAB award over one year on prediction of residual pulmonary hypertension after endarterectomy: clinical and omics approach. (12/30/23-12/31/24)
  • $150,000 Breast Cancer Research Foundation (BCRF) award over two years on biomarker assessment in patients with node-positive breast cancer. (10/01/22-9/30/24)
  • $150,000 Mayo Clinic Breast Cancer SPORE DRP award over two years on developing population-specific risk prediction models for underserved populations with triple-negative breast cancer. (11/15/22-11/14/24)
  • $66,667 Emory - Departments of Pathology + Radiology + Informatics Grants award over one year on bridging AI/ML radio-path imaging and liquid biopsy to predict the origin and molecular profile of brain metastasis. (11/01/23-10/31/24)
  • $50,000 Georgia CTSA Seed Grant Award over two years on Liver Radiomics-based Nomogram (LT-RadNom) for early detection and prognosis of heart failure. (07/17/23-07/18/25)
  • $50,000 Emory - Winship Invest$ Summer 2022 Discovery & Developmental Therapeutics Research Domain award over two years on development of radiomics based imaging biomarkers to predict response to neoadjuvant targeted therapy in patients with advanced renal cell cancer. (02/01/23-01/31/25)
  • $50,000 Mike Slive Foundation award over a year on Artificial Intelligence (AI) based Radio-Pathetic Nomogram to prognosticate treatment outcomes in prostate cancer patients following radical prostatectomy. (01/01/24-12/31/24)
  • $50,000 Emory - Winship Lung Cancer SPORE CEP award over two years on predicting treatment response for immunotherapy in NSCLC by novel imaging biomarkers. (01/01/24-12/31/26)
  • $48,600 DoD award over five years on analysis of tissue architecture to identify lethal prostate cancer in the Veteran population. (06/01/21-05/30/26)
  • $30,000 Case Western Reserve University award over one year on Tanzania-Uganda U54 HIV-associated cancer short-term developmental pilot award novel imaging biomarkers for predicting overall survival in people living with HIV (PLWH) diagnosed with lung cancer. (05/01/24-04/30/25)